ÂÜÀòÂÒÂ×

Wojciech Dworakowski is an experienced leader in toxicology and drug metabolism, currently serving as Vice President of Toxicology and DMPK at both Flagship Pioneering and Pioneering Medicines since August 2022, while also holding the position of Executive Director at Syros Pharmaceuticals since November 2019. With a background that includes significant roles at Vertex Pharmaceuticals and the University of Pennsylvania, Dworakowski has demonstrated expertise in non-clinical pharmacology, DMPK, and the advancement of drug candidates. Educational qualifications include an MBA from Boston University, a PhD in Drug Metabolism from the Medical University of Bialystok, and comprehensive training in business management from The Wharton School and biology from the University of Warsaw.